clinical efficacy , increased lung selectivity , and improved delivery ( a breath-actuated multi-dose pure drug powder device will soon be available for inhalational glucocorticoid therapy ) would speed up the current trend towards using glucocorticoids as primary and prophylactic treatment of asthma .
C0024109
lung
C0004096
asthma